Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:17 PM
Ignite Modification Date:
2025-12-24 @ 5:17 PM
NCT ID:
NCT04401150
Eligibility Criteria:
Inclusion Criteria:
* Confirmed diagnosis of COVID-19;
* Admitted to hospital (ward or intensive care unit).
Exclusion Criteria:
* Receiving or has received vasopressors during the current hospitalization;
* More than 24 hours has elapsed since receipt of non-invasive ventilatory support (high-flow nasal cannula or continuous positive airway pressure or non-invasive ventilation) or invasive mechanical ventilation;
* Patient is expected to be discharged from the hospital in the next 24 hours;
* More than 14 days have elapsed since the commencement of hospital admission with respiratory illness;
* Known glucose-6-phosphate dehydrogenase (G6PD) deficiency;
* Known sickle cell anemia
* Pregnancy or breastfeeding;
* Known allergy to vitamin C;
* Known kidney stones within the past 1 year;
* Received any intravenous vitamin C during this hospitalization unless incorporated in parenteral nutrition;
* Expected death or withdrawal of life-sustaining treatments within 48 hours;
* Previously enrolled in this study;
* Previously enrolled in a trial for which co-enrolment is not allowed (co- enrolment to be determined case by case).
The trial has broad eligibility criteria and includes all COVID-19 patients admitted to the hospital (e.g. hospital ward or the intensive care unit) who are not receiving vasopressors.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04401150
Study Brief:
Protocol Section:
NCT04401150